Generex Inks $50 Million Licensing Deal with China Partners on the Cooperative Development of the Ii-Key Vaccine Platform

by NASDAQ Market News November 18, 2020

NASDAQ Market News
Click here to email author

AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021

Fortress Biotech Ranked in Deloitte’s Technology Fast 500™ for the Second Year in a Row

Ads